Search research articles
Contact Us
Filters
Showing results (21-30 of 52) with videos related to
Page
of 6
Sort By:
Blood
|
August 4, 2025
A precision medicine approach to the myelodysplastic syndrome with isolated deletion 5q 50 years after its discovery
Marco Roncador, Elsa Bernard, Robert P Hasserjian, et al.
Research Square
|
April 24, 2023
The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblasts
In Young Choi, Jonathan Ling, Jian Zhang, et al.
Blood Advances
|
February 11, 2021
Modulation of IL-6/STAT3 signaling axis in CD4+FOXP3- T cells represents a potential antitumor mechanism of azacitidine
Eleftheria Lamprianidou, Chryssoula Kordella, Anastasiya Kazachenka, et al.
Blood Advances
|
January 18, 2022
Patient-specific MDS-RS iPSCs define the mis-spliced transcript repertoire and chromatin landscape of SF3B1-mutant HSPCs
Georgios Asimomitis, André G Deslauriers, Andriana G Kotini, et al.
Leukemia
|
March 12, 2022
"Randomized phase II study of azacitidine ± lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del(5q)"
Bengt Rasmussen, Gudrun Göhring, Elsa Bernard, et al.
Transplantation and Cellular Therapy
|
September 9, 2021
Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelomonocytic Leukemia: Clinical and Molecular Genetic Prognostic Factors in a Nordic Population
Eileen Wedge, Jakob Werner Hansen, Ingunn Dybedal, et al.
Blood Advances
|
May 17, 2024
The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblasts
In Young Choi, Jonathan P Ling, Jian Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 27, 2023
Integrated Genomic and Transcriptomic Analysis Improves Disease Classification and Risk Stratification of MDS with Ring Sideroblasts
Gabriele Todisco, Maria Creignou, Elsa Bernard, et al.
Journal of Internal Medicine
|
April 24, 2024
Early transfusion patterns improve the Molecular International Prognostic Scoring System (IPSS-M) prediction in myelodysplastic syndromes
Maria Creignou, Elsa Bernard, Alessandro Gasparini, et al.
Nature Communications
|
August 8, 2022
Unified classification and risk-stratification in Acute Myeloid Leukemia
Yanis Tazi, Juan E Arango-Ossa, Yangyu Zhou, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 52) with videos related to
Sort By:
Page
of 6
Blood
|
August 4, 2025
A precision medicine approach to the myelodysplastic syndrome with isolated deletion 5q 50 years after its discovery
Marco Roncador, Elsa Bernard, Robert P Hasserjian, et al.
Research Square
|
April 24, 2023
The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblasts
In Young Choi, Jonathan Ling, Jian Zhang, et al.
Blood Advances
|
February 11, 2021
Modulation of IL-6/STAT3 signaling axis in CD4+FOXP3- T cells represents a potential antitumor mechanism of azacitidine
Eleftheria Lamprianidou, Chryssoula Kordella, Anastasiya Kazachenka, et al.
Blood Advances
|
January 18, 2022
Patient-specific MDS-RS iPSCs define the mis-spliced transcript repertoire and chromatin landscape of SF3B1-mutant HSPCs
Georgios Asimomitis, André G Deslauriers, Andriana G Kotini, et al.
Leukemia
|
March 12, 2022
"Randomized phase II study of azacitidine ± lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del(5q)"
Bengt Rasmussen, Gudrun Göhring, Elsa Bernard, et al.
Transplantation and Cellular Therapy
|
September 9, 2021
Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelomonocytic Leukemia: Clinical and Molecular Genetic Prognostic Factors in a Nordic Population
Eileen Wedge, Jakob Werner Hansen, Ingunn Dybedal, et al.
Blood Advances
|
May 17, 2024
The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblasts
In Young Choi, Jonathan P Ling, Jian Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 27, 2023
Integrated Genomic and Transcriptomic Analysis Improves Disease Classification and Risk Stratification of MDS with Ring Sideroblasts
Gabriele Todisco, Maria Creignou, Elsa Bernard, et al.
Journal of Internal Medicine
|
April 24, 2024
Early transfusion patterns improve the Molecular International Prognostic Scoring System (IPSS-M) prediction in myelodysplastic syndromes
Maria Creignou, Elsa Bernard, Alessandro Gasparini, et al.
Nature Communications
|
August 8, 2022
Unified classification and risk-stratification in Acute Myeloid Leukemia
Yanis Tazi, Juan E Arango-Ossa, Yangyu Zhou, et al.
Page
of 6